I wonder if research has any more info on Rytary?
I have been following the long, problematic journey of this new drug for some years and at last it looks as if it may become available soon.
A Levadopa drug that is able to stay in he system for longer, meaning fewer doses are needed would be so much better .
Hi goldengirl, I've asked our Research team to reply to this one so look out for an update tomorrow.
Thanks for your query following up on Rytary. We’ve done some research and found that the drug manufacturer ‘Impax laboratories inc’ resubmitted their new drug application for Rytary to the FDA on 11 April 2014.
You can read the full press release here - http://bit.ly/1jczYzE
It’s difficult to say how long it will take to process this application but we’ll keep an eye out for any developments. It will be a very promising step in the right direction if the application is approved.
The Research Team